Nirali Shah, MD, MHSc, Receives Frank A. Oski Memorial Lectureship at ASPHO | Blood Cancers Today
Dr. Shah’s areas of expertise include immunology and immunotherapy, rare tumors, CAR T-cell therapies, and transplantation.
Dr. Shah’s areas of expertise include immunology and immunotherapy, rare tumors, CAR T-cell therapies, and transplantation.
Wednesday, June 19, 2024, 5:00 PM – 6:00 PM Register for this complimentary event with the “Register Now” button above, which will take you to…
Momelotinib led to “superior” symptom and spleen responses and transfusion independence rates compared to danazol in thrombocytopenic myelofibrosis.
1ª Conferência Internacional a Doença Falciforme nos Países da CPLP
This issue of Blood Cancers Today includes a feature on secondary malignancies after CAR T-cell therapy; a Get to Know with Julie Vose, MD; and…
LIVE WEBINAR: Tuesday, June 18, 2024 | 5:00 PM – 6:00 PM Eastern Time (ET) Register for this complimentary event with the “Register Now” button…
This retrospective cohort study quantifies and compares home time for older patients with newly diagnosed acute myeloid leukemia receiving either hypomethylating agents or anthracycline-based chemotherapy.
Review exclusive coverage of the MPN-focused discussions and insights from The HemOnc Pulse Live, May 3-4, 2024, in Chicago.
The combination of pelabresib plus ruxolitinib improved spleen and symptom responses in JAKi-naïve patients with myelofibrosis.
Research To Practice requires users to log in to view educational content. All content is available without
Welcome to the website for the Canadian Hematology Training Programs. This website contains information about educational activities and resources relevant to hematology trainees and educators…